A new trading day began on Tuesday, with Prothena Corporation plc (NASDAQ: PRTA) stock price up 3.14% from the previous day of trading, before settling in for the closing price of $9.86. PRTA’s price has ranged from $4.32 to $18.88 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -3.15% over the last five years. Meanwhile, its annual earnings per share averaged -106.36%. With a float of $43.46 million, this company’s outstanding shares have now reached $53.83 million.
Prothena Corporation plc (PRTA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Prothena Corporation plc is 19.26%, while institutional ownership is 78.10%. The most recent insider transaction that took place on May 02 ’25, was worth 27,744,929. In this transaction 10% Owner of this company sold 3,317,938 shares at a rate of $8.36, taking the stock ownership to the 8,266,342 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 1,984,053 for $7.64, making the entire transaction worth $15,164,712. This insider now owns 5,304,596 shares in total.
Prothena Corporation plc (PRTA) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.1 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -106.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.23% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Here are Prothena Corporation plc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 52.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.63, a number that is poised to hit -0.69 in the next quarter and is forecasted to reach 0.15 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Analysing the last 5-days average volume posted by the [Prothena Corporation plc, PRTA], we can find that recorded value of 0.79 million was lower than the volume posted last year of 1.03 million. As of the previous 9 days, the stock’s Stochastic %D was 76.25%.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 95.28%, which indicates a significant increase from 88.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.46 in the past 14 days, which was higher than the 0.38 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.38, while its 200-day Moving Average is $9.94. Now, the first resistance to watch is $10.39. This is followed by the second major resistance level at $10.61. The third major resistance level sits at $10.84. If the price goes on to break the first support level at $9.94, it is likely to go to the next support level at $9.70. Now, if the price goes above the second support level, the third support stands at $9.48.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
With a market capitalization of 547.45 million, the company has a total of 53,830K Shares Outstanding. Currently, annual sales are 135,160 K while annual income is -122,310 K. The company’s previous quarter sales were 4,420 K while its latest quarter income was -125,770 K.
